339 related articles for article (PubMed ID: 37760612)
1. Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells.
Afrin F; Mateen S; Oman J; Lai JCK; Barrott JJ; Pashikanti S
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760612
[TBL] [Abstract][Full Text] [Related]
2. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
3. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
4. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
5. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
6. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
7. Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.
Separovic D; Breen P; Boppana NB; Van Buren E; Joseph N; Kraveka JM; Rahmaniyan M; Li L; Gudz TI; Bielawska A; Bai A; Bielawski J; Pierce JS; Korbelik M
Int J Oncol; 2013 Dec; 43(6):2064-72. PubMed ID: 24126464
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of enzymes in the ceramide metabolic pathway in human retinal pigment epithelial cells and their relevance to retinal degeneration.
Zhu D; Sreekumar PG; Hinton DR; Kannan R
Vision Res; 2010 Mar; 50(7):643-51. PubMed ID: 19765607
[TBL] [Abstract][Full Text] [Related]
9. Quantifying Fluorescently Labeled Ceramide Levels in Human Sarcoma Cell Lines in Response to a Sphingomyelin Synthase Inhibitor.
Pashikanti S; Afrin F; Meldrum TC; Stegelmeier JL; Pavek A; Habashi YA; Fatema K; Barrott JJ
Methods Protoc; 2019 Aug; 2(3):. PubMed ID: 31480447
[TBL] [Abstract][Full Text] [Related]
10. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
13. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase.
Facchinetti MM; Beuret C; Marquez MG; Sterin-Speziale N
Biol Neonate; 2003; 84(3):243-51. PubMed ID: 14504448
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
[TBL] [Abstract][Full Text] [Related]
15. The Role of Sphingolipids Metabolism in Cancer Drug Resistance.
Bataller M; Sánchez-García A; Garcia-Mayea Y; Mir C; Rodriguez I; LLeonart ME
Front Oncol; 2021; 11():807636. PubMed ID: 35004331
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
Gencer EB; Ural AU; Avcu F; Baran Y
Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
[TBL] [Abstract][Full Text] [Related]
19. Increase in sphingolipid catabolic enzyme activity during aging.
Sacket SJ; Chung HY; Okajima F; Im DS
Acta Pharmacol Sin; 2009 Oct; 30(10):1454-61. PubMed ID: 19749786
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma.
Miura K; Nagahashi M; Prasoon P; Hirose Y; Kobayashi T; Sakata J; Abe M; Sakimura K; Matsuda Y; Butash AL; Katsuta E; Takabe K; Wakai T
Hepatol Res; 2021 May; 51(5):614-626. PubMed ID: 33586816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
